Karyotypic analysis at time of diagnosis has an important value in determining initial
response to treatment, remission duration and overall survival (OS) in acute myeloid …

Baseline cytogenetics and disease status are key factors predicting the outcomes of
allogeneic hematopoietic cell transplantation (HCT) in patients with acute myeloid leukemia …

Allogeneic hematopoietic stem cell transplantation (HSCT) offers the best chance for relapse-
free survival to most patients with acute myeloid leukemia (AML). It may be performed during …

Baseline cytogenetic studies at diagnosis remain the single most important determinant of
outcome in patients with acute myeloid leukemia (AML). However, the prognostic role of the …

While evidence for measurable residual disease (MRD) is a harbinger of inferior outcome in
acute myeloid leukemia (AML) patients referred for allogeneic stem cell transplantation (allo …

FMS‐like tyrosine kinase 3 internal tandem duplication (FLT3‐ITD) mutational status is a
pivotal prognosticator in acute myeloid leukemia (AML) patients and significantly increases …

Several studies have shown that allogeneic hematopoietic cell transplantation (HCT) in first
complete remission (CR1) of AML reduces the risk of relapse and improves relapse-free …

This study aimed at determining how cytogenetic risk status affects outcomes for patients
with acute myeloid leukemia (AML) after undergoing various types of allogeneic …

Background: Allogeneic hematopoietic stem-cell transplantation (ahsct) is associated with
significant morbidity and mortality, but it can cure carefully selected patients with acute …

Purpose To determine to what extent allogeneic hematopoietic stem-cell transplantation
(alloHSCT) quantitatively reduces relapse in acute myeloid leukemia with monosomal …